Role of nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo

Kidney and Blood Pressure Research

Volumn 26, Issue 3, 2003, Pages 165-175

  Handa, Rajash K ^a,b   Strandhoy, Jack W ^a   Handa, Shelly E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow; Blood pressure; Kidney; Nitric oxide; Platelet activating factor; Rat

Indexed keywords

ACETYLCHOLINE; ARGIPRESSIN; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANESTHESIA; ANIMAL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG INHIBITION; ENZYME INHIBITION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INJECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; RENAL ARTERY; SYSTEMIC CIRCULATION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INJECTIONS; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR; RENAL CIRCULATION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0043175476     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071882     Document Type: Article

References (37)

1. Evangelou AM: Platelet-activating factor: Implications for coronary heart and vascular diseases. Prostaglandins Leukot Essent Fatty Acids 1994;50:1-28.
2. Ishii S, Shimizu T: Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 2000;39:41-82.
3. López-Novoa JM: Potential role of platelet-activating factor in acute renal failure. Kidney Int 1999;55:1672-1682.
4. Schlondorff D, Neuwirth R: Platelet-activating factor and the kidney. Am J Physiol 1986;251:F1-F11.
5. McGowan HM, Vandingen R, Kelly LD, Hill KJ: Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. Clin Sci 1988;74:393-396.
6. Sakaguchi K, Morimoto S, Masugi F, Saeki S, Ogihara T, Yamada K, Yamatsu I: Studies on the role of platelet-activating factor in blood pressure regulation. Lipids 1991;26:1264-1268.
7. Asano K, Taniguchi S, Nakao A, Watanabe T, Kurokawa K: Distribution of platelet-activating factor receptor mRNA along the rat nephron segments. Biochem Biophys Res Commun 1996;225:352-357.
8. Hirashima Y, Kato R, Endo S, Takaku A, Karasawa K, Nojima S: Immunofluorescent localization of platelet-activating factor in the rat. Histochem J 1993;25:830-833.
9. 2. Am J Physiol 1989;256:F35-F43.
10. Hébert RL, Sirois P, Plante GE: Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655,240, a new thromboxane-prostaglandin endoperoxide antagonist. Can J Physiol Pharmacol 1989;67:304-308.
11. Yoo J, Schlondorff D, Neugarten J: Thromboxane mediates the renal hemodynamic effects of platelet-activating factor. J Pharmacol Exp Ther 1990;253:743-748.
12. Cailleaux S, Lopes-Martins RAB, Aimbire F, Cordeiro RSB, Tibiricá E: Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney. Naunyn Schmiedebergs Arch Pharmacol 1999;359:505-511.
13. Schwertschlag U, Scherf H, Gerber JG, Mathias M, Nies AS: L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. Circ Res 1987;60:534-549.
14. Handa RK, Strandhoy JW, Buckalew VM Jr: Platelet-activating factor is a vasodilator in the anesthetized rat. Am J Physiol 1990;258:F1504-F1509.
15. Handa RK, Strandhoy JW, Buckalew VM Jr: Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney. Am J Physiol 1991;261:F108-F116.
16. Laurindo FRM, Goldstein RE, Davenport NJ, Ezra D, Feuerstein GZ: Mechanisms of hypotension produced by platelet-activating factor. J App Physiol 1989;66:2681-2690.
17. Yamanaka S, Miura K, Yukimura T, Okumura M, Yamamoto K: Putative mechanism of hypotensive action of platelet-activating factor in dogs. Circ Res 1992;70:893-901.
18. Tanaka Y, Hayakawa S, Imai T, Akutsu A, Hirano H, Tanaka H, Nakhara T, Ishii K, Shigenobu K: Possible involvement of endothelium-derived hyperpolarizing factor in the depressor responses to platelet-activating factor in rats. Br J Pharmacol 2000;131:1113-1120.
19. Duràn WN, Seyama A, Yoshimura K, Gonzàlez DR, Jara PI, Figueroa XF, Borić MP: Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. Microvasc Res 2000;60:104-111.
20. Fabi F, Calabrese R, Stati T, Basso P: Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: Interaction between NO synthase and cyclo-oxygenase-2 pathways. Br J Pharmacol 2001;134:777-788.
21. Yoshikawa D, Shiga T, Saito S, Morita T, Imai T, Goto F: Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat. Eur J Pharmacol 1998;342:241-245.
22. Ay I, Emre S, Tuncer M: Factors responsible for acetylcholine-induced dilatation in the isolated perfused rat kidney. Gen Pharmacol 2000;34:175-181.
23. Hayashi K, Loutzenhiser R, Epstein M, Suzuki H, Saruta T: Multiple factors contribute to acetylcholine-induced renal afferent arteriolar vasodilation during myogenic and norepinephrine- and KCl-induced vasoconstriction: Studies in the isolated perfused hydronephrotic kidney. Circ Res 1994;75:821-828.
24. Handa RK, Strandhoy JW: Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo. J Pharmacol Exp Ther 1996;277:1486-1491.
25. 18-PAF on renal blood flow and systemic blood pressure in the anesthetized rat. Life Sci 1991;49:747-752.
26. Mattson DL, Roman RJ, Cowley AW Jr: Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 1992;19:766-769.
27. Juncos LA, Ren Y, Arima S, Ito S: Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney: Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products. J Clin Invest 1993;91:1374-1379.
28. Filep JG, Földes-Filep É: Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br J Pharmacol 1993;110:1347-1352.
29. Greenberg SS, Xie J, Powers DR, Giles TD: Ethanol suppresses endotoxin but not platelet-activating factor-induced hypotension and nitric oxide. Alcohol Clin Exp Res 1996;20:1260-1268.
30. Yoshikawa T, Takano H, Yamamoto H, Nakahashi Y, Yamaguchi T, Arimoto T, Kondo M: Role of superoxide and nitric oxide in platelet-activating factor-induced acute lung injury, hypotension, and mortality in rats. Crit Care Med 1997;25:286-292.
31. Noguchi K, Matsuzaki T, Shiroma N, Ojiri Y, Sakanashi M: Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. Br J Pharmacol 1996;118:941-950.
32. Wang HG, Shibamoto T, Matsuda Y, Koyama S: The role of endogenous nitric oxide in the sympathetic and hemodynamic response to platelet-activating factor-induced hypotension in anesthetized dogs. Shock 1998;9:58-64.
33. Szabó C, Wu CC, Mitchell JA, Gross SS, Thiemermann C, Vane JR: Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993;73:991-999.
34. Vargas HM, Cuevas JM, Ignarro LJ, Chaudhuri G: Comparison of the inhibitory potencies of N(G)-methyl-,N(G)-nitro- and V(G)-amino-L-arginine on EDRF function in the rat: Evidence for continuous basal EDRF release. J Pharmacol Exp Ther 1991;257:1208-1215.
35. Lahera V, Khraibi AA; Romero JC: Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats. Hypertension 1993;22:156-160.
36. Hendriks MG, Pfaffendorf M, van Zwieten PA: The role of nitric oxide and potassium channels in endothelium-dependent vasodilation in SHR. Blood Press 1993;2:233-243.
37. Bakker EN, Balt JC, Pfaffendorf M, Spaan JA, VanBavel E: Vasomotor effects of arg-gly-asp (RGD) peptides are limited and not related to endothelium-derived hyperpolarizing factor-mediated relaxation in rat mesenteric arteries. Clin Exp Pharmacol Physiol 2001;28:873-976.